Fracture Internal X-fixation With Augmented Reality and Radiolucent Ring Retraction (FIXAR)

November 13, 2026 updated by: Prof. Christian Xinshuo Fang, The University of Hong Kong

Fracture Internal X-fixation With Augmented Reality and Radiolucent Ring Retraction: A Prospective Randomised Controlled Trial

The surgical management of distal radius fractures via open reduction and internal fixation (ORIF) remains the gold standard for restoring wrist function. However, the procedure is traditionally characterized by repetitive workflow interruptions of the removal of metallic retractors to avoid radiological artifacts and the ergonomic strain of the "head-turn" required to view distant fluoroscopy monitors.

The Radius Radiolucent Ring Retractor (RRRR) is a single-use, 3D-printed nylon surgical device designed for hands-free retraction in arm and wrist surgeries. This device was developed at the University of Hong Kong and invention is held by HKU Versitech Limited.

This study aims to definitively evaluate the gadget-optimized distal radius fixation surgery with the RRRR and head-mounted Augmented Reality glasses display to optimize the surgical workflow. This trial will evaluate whether this system provides a more efficient alternative to conventional monitor-based fluoroscopy in modern orthopedic practice.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

94

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Christian Prof. Fang
  • Phone Number: +852 22554581
  • Email: cfang@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Queen Mary Hospital, The University of Hong Kong
        • Contact:
          • Christian Prof. Fang
          • Phone Number: +852 22554581
          • Email: cfang@hku.hk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults (18-85 years)
  • Distal radial fractures requiring Open Reduction and Internal Fixation.
  • Patients that would be suitable for the volar approach.

Exclusion Criteria:

  • Open fractures
  • Active infection
  • Polytrauma patients where the wrist is not the primary focus.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Radius Radiolucent Ring Retractor and the Augmented Reality Glasses

The surgery will be completed with the combination of Radius Radiolucent Ring Retractor (RRRR) and Augmented Reality Glasses.

The RRRR is a 3D-printed surgical tool designed for hands-free retraction in arm and wrist surgeries.

The Augmented Reality Glasses for surgeons designed specifically for surgeons can display real-time X-ray images directly in the doctor's field of vision, allowing the doctor to focus on the wrist throughout the procedure without having to turn their head to look at the X-ray screen.

The Radius Radiolucent Ring Retractor (RRRR) is a single-use, 3D-printed nylon surgical device designed for hands-free retraction in arm and wrist surgeries.

Augmented Reality of C-Arm intraoperative fluoroscopic imaging integration with a head mount-display (HMD).

Active Comparator: Metal tools and standard X-ray monitor

Traditional method with metal retractors and standard X-ray monitor.

Manual traditional metal retractor used by surgeons and assistants.

Standard X-ray monitor that displays fluoroscopy images during the operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Fluoroscopy Time
Time Frame: Intra-operative

The total duration, measured in minutes or seconds, that the X-ray beam is actively turned on during a fluoroscopic procedure during the operation.

Intra-operative
Functional Assessment measured by QuickDASH Score
Time Frame: At post-op, 3 weeks, 6 weeks , 3 months and 6 months

The QuickDASH score is a validated, internationally recognized tool to assess functional outcomes of patients of the upper arm, especially in long term recovery assessments. The survey will assess the control group against intervention group in return to daily activities, assessment of overall upper limb function, symptoms, and quality of life.

At post-op, 3 weeks, 6 weeks , 3 months and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rating of placement of implant using 25 point Surgeon-Reported Outcome Measures
Time Frame: Immediately after operation

The qualitative assessment of 1 to 5 of the placement of implant rated by the surgeon.

Immediately after operation
Rating of ergonomics and visualisation of plate position using 25 point Surgeon-Reported Outcome Measures
Time Frame: Immediately after operation

The qualitative assessment of 1 to 5 of the ergonomics and visualisation of plate position rated by the surgeon.

Immediately after operation
Rating of retraction during fluoroscopy using 25 point Surgeon-Reported Outcome Measures
Time Frame: Immediately after operation

The qualitative assessment of 1 to 5 of the retraction during fluoroscopy rated by the surgeon.

Immediately after operation
Rating of fracture reduction using 25 point Surgeon-Reported Outcome Measures
Time Frame: Immediately after operation

The qualitative assessment of 1 to 5 of the quality of fracture reduction rated by the surgeon.

Immediately after operation
Rating of overall assistants' efforts using 25 point Surgeon-Reported Outcome Measures
Time Frame: Immediately after operation

The qualitative assessment of 1 to 5 of the quality of overall assistants' efforts rated by the surgeon.

Immediately after operation
Number of surgical assistants
Time Frame: Intra-operative

The maximum number of surgical assistants required for retraction tasks at any single point during the surgery.

Intra-operative
Number of times retractors were removed and replaced
Time Frame: Intra-operative

The number of times the whole RRRR or the metal retractor is lifted out of the incision site, then putting it back count as 1.

Intra-operative
Number of times the retractor was loosened from the surgical site
Time Frame: Intra-operative

The number of times the traditional retractor or RRRR is not adequately retracting the surgical wound and providing a clear view of the fracture site,

Intra-operative
Number of readjustments for fracture reduction
Time Frame: Intra-operative

The number of times that a fracture reduction is changed during the operation.

Intra-operative
Number of attempts for repositioning Kirschner wire
Time Frame: Intra-operative

The numbers of times the Kirschner wire is removed from the incision site and then putting it back count as 1.

Intra-operative
Maximum number of Kirschner wire used to maintain positioning and/or reduction
Time Frame: Intra-operative

The maximum number of Kirschner wires at any time point that are used to maintain implant positioning and/or fracture reduction.

Intra-operative
Number of repositioning of plates
Time Frame: Intra-operative

The number of times the implant plate is moved and repositioned is recorded as 1.

Intra-operative
Number of repositioning of screws
Time Frame: Intra-operative

The number of times the screw is removed from the incision site and repositioned is recorded as 1.

Intra-operative
Total number of screws used in the operation
Time Frame: Intra-operative

The total number of screws that are used in the operation, including those that are implanted or wasted.

Intra-operative
Number of head turns to assess x-ray images
Time Frame: Intra-operative

The number of times the primary surgeon looks at the fluoroscopy monitor during fracture reduction.

Intra-operative
Number of times the eyepiece focus is lost
Time Frame: Intra-operative

The number of times the AR HMD eyepiece is out of focus is recorded as 1.

Intra-operative
Duration of surgery
Time Frame: Intra-operative

Defined from the time difference of the incision start time and the completion time of final suturing.

Intra-operative
Incision Length in mm
Time Frame: Intra-operative

Defined as the length in millimeters of the incision cut in the surgery.

Intra-operative
Radial Inclination in degrees
Time Frame: At post-op, 3 weeks, 6 weeks , 3 months and 6 months

Measurement of the coronal-plane slope of the distal radius articular surface, measured in pre-operative and post-operative wrist x-ray.

At post-op, 3 weeks, 6 weeks , 3 months and 6 months
Radial Height in millimeters
Time Frame: At post-op, 3 weeks, 6 weeks , 3 months and 6 months

Measurement of the axial distance between perpendicular lines at the radial styloid and ulnar border, quantifying fracture-induced radial shortening, measured in pre-operative and post-operative wrist x-ray.

At post-op, 3 weeks, 6 weeks , 3 months and 6 months
Volar / Dorsal Angulation in degrees
Time Frame: At post-op, 3 weeks, 6 weeks , 3 months and 6 months

Measurement of the tilt of the distal articular surface relative to the shaft, measured in pre-operative and post-operative wrist x-ray.

At post-op, 3 weeks, 6 weeks , 3 months and 6 months
Articular Step-off in millimeters
Time Frame: At post-op, 3 weeks, 6 weeks , 3 months and 6 months

Measurement of the vertical incongruity along the subchondral surface, measured in pre-operative and post-operative wrist x-ray.

At post-op, 3 weeks, 6 weeks , 3 months and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Christian Prof. Fang, Dept of Orthopaedics and Traumatology, Queen Mary Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

March 31, 2028

Study Registration Dates

First Submitted

October 26, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • UW 26-371

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized dataset to be included as supplementary data in final publication

IPD Sharing Time Frame

Within 1 year of study completion

IPD Sharing Access Criteria

Additional information available upon reasonable request of principal investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.